Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Thumb Osteoarthritis: later-stage trial registry

3 of 5 indexed Thumb Osteoarthritis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Thumb Osteoarthritis: 5 US clinical trials tracked, 3 recruiting.

Thumb Osteoarthritis is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 1 of these trials.

Enrollment posture brief

Registry condition thumb-osteoarthritis

OPEN 3 | RECR 60% | LATE 1 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Thumb Osteoarthritis (this)60%
Open-enrollment share among volume-matched conditions near Thumb Osteoarthritis

Thumb Osteoarthritis lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Thumb Osteoarthritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Thumb Osteoarthritis is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Thumb Osteoarthritis research.

    Johns Hopkins University accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Thumb Osteoarthritis trials plan to enrol fewer than 100 people.

    Median target enrolment is 61 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.

  4. Thumb Osteoarthritis research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Thumb Osteoarthritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

trapeziectomy with ligament reconstruction (LRTI) Procedure
1 trials
Denervation of the thumb CMC joint Procedure
1 trials
Sham PEMF device Device
1 trials
PEMF device Device
1 trials
Turmeric Dietary supplement
1 trials
Triamcinolone Drug
1 trials
Immobilization for 6-weeks postoperative Other
1 trials
Immobilization for 2-weeks postoperative Other
1 trials

US sites by state

Facility locations filed on Thumb Osteoarthritis trials. A trial with sites in several states counts in each.

Minnesota 1 trials
Maryland 1 trials
Massachusetts 1 trials
Illinois 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Thumb Osteoarthritis page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thumb Osteoarthritis condition card totals 5 registered trials; most-linked intervention trapeziectomy with ligament reconstruction (LRTI); top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.